GRIT BIOTECHNOLOGY
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors. The company was founded in 2019 and is headquartered in Shanghai, China.
GRIT BIOTECHNOLOGY
Industry:
Biotechnology Health Care Medical Device
Founded:
2019-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.grit-bio.com
Status:
Active
Total Funding:
15 M USD
Similar Organizations
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Newsoara
Newsoara is a biomedical technology developer that specializes in the development of medical devices.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Current Employees Featured
Founder
Investors List
Hillhouse Capital Group
Hillhouse Capital Group investment in Series A - GRIT Biotechnology
Decheng Capital
Decheng Capital investment in Series A - GRIT Biotechnology
Matrix Partners China
Matrix Partners China investment in Series A - GRIT Biotechnology
Apricot Capital
Apricot Capital investment in Series A - GRIT Biotechnology
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences investment in Series A - GRIT Biotechnology
Decheng Capital
Decheng Capital investment in Series A - GRIT Biotechnology
Matrix Partners China
Matrix Partners China investment in Series A - GRIT Biotechnology
